Martin Connolly, S. Wort, B. Garfield, A. Crosby, N. Morrell, P. Kemp
{"title":"MiR-1-5p targets TGF-ßR1 and is suppressed in the hypertrophying hearts of rats with pulmonary arterial hypertension","authors":"Martin Connolly, S. Wort, B. Garfield, A. Crosby, N. Morrell, P. Kemp","doi":"10.1183/13993003.congress-2019.pa5045","DOIUrl":null,"url":null,"abstract":"MicroRNAs (miRNAs) are small, non-coding RNAs, implicated in the control of myocardial homeostasis. miR-1 has been shown to be down-regulated in hypertrophying rodent hearts and its restoration an ameliorating factor. We used monocrotaline treatment to induce pulmonary hypertension in a cohort of rats and thereafter-showed miR-1 expression was reduced in the hypertrophying right ventricle (RV) (Fig. 1A). Bioinformatic analysis identified TGF-βR1 (ALK5) as a predicted target for miR-1, the expression of which was increased in the RV (Fig. 1B, C). Cell transfection with a miR-1-mimic reduced GFP expression from a reporter vector containing the ALK5 3’-UTR and also knocked down endogenous ALK5. Lastly, miR-1 reduced TGF-β activation of a SMAD2/3-dependent reporter. Taken together, these data confirm miR-1 targets TGF-βR1 thereby reducing TGF-β signalling, which may regulate cardiac hypertrophy.","PeriodicalId":20724,"journal":{"name":"Pulmonary hypertension","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2019-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pulmonary hypertension","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1183/13993003.congress-2019.pa5045","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1
Abstract
MicroRNAs (miRNAs) are small, non-coding RNAs, implicated in the control of myocardial homeostasis. miR-1 has been shown to be down-regulated in hypertrophying rodent hearts and its restoration an ameliorating factor. We used monocrotaline treatment to induce pulmonary hypertension in a cohort of rats and thereafter-showed miR-1 expression was reduced in the hypertrophying right ventricle (RV) (Fig. 1A). Bioinformatic analysis identified TGF-βR1 (ALK5) as a predicted target for miR-1, the expression of which was increased in the RV (Fig. 1B, C). Cell transfection with a miR-1-mimic reduced GFP expression from a reporter vector containing the ALK5 3’-UTR and also knocked down endogenous ALK5. Lastly, miR-1 reduced TGF-β activation of a SMAD2/3-dependent reporter. Taken together, these data confirm miR-1 targets TGF-βR1 thereby reducing TGF-β signalling, which may regulate cardiac hypertrophy.